Literature DB >> 9848015

Recent advances in developing neuroprotective strategies for perinatal asphyxia.

N J Robertson1, A D Edwards.   

Abstract

Perinatal asphyxia is the most important cause of acute neurologic injury in the newborn and occurs in approximately six per 1000 term live births. After resuscitation of an infant with birth asphyxia, the emphasis has been on supportive therapy; however, there is increasing evidence that a "therapeutic window" exists in the early hours following the insult, and perhaps for longer, when intervention can attenuate activation of the neurotoxic cascade that leads to delayed cell death hours, days or months later.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848015     DOI: 10.1097/00008480-199810060-00006

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report.

Authors:  A J Barkovich; K D Westmark; H S Bedi; J C Partridge; D M Ferriero; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

2.  Therapeutic window for cycloheximide treatment after hypoxic-ischemic brain injury in neonatal rats.

Authors:  Won Soon Park; Dong Kyung Sung; Saem Kang; Soo Hyun Koo; Yu Jin Kim; Jang Hoon Lee; Yun Sil Chang; Munhyang Lee
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

3.  Neonatal encephalopathies. Time to reconsider the cause of encephalopathies.

Authors:  A D Edwards; K B Nelson
Journal:  BMJ       Date:  1998-12-05

4.  Delayed hypothermia prevents decreases in N-acetylaspartate and reduced glutathione in the cerebral cortex of the neonatal pig following transient hypoxia-ischaemia.

Authors:  Keith J Brooks; Iain Hargreaves; Kishore Bhakoo; Mark Sellwood; Francis O'Brien; Martina Noone; Yasuko Sakata; Ernest Cady; Marzena Wylezinska; John Thornton; Roger Ordidge; Quyen Nguyen; Matthew Clemence; John Wyatt; Timothy E Bates
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.